End-of-day quote
Korea S.E.
06:00:00 2024-06-27 pm EDT
|
5-day change
|
1st Jan Change
|
10,750
KRW
|
+1.22%
|
|
-9.36%
|
-27.51%
|
Fiscal Period: December |
2023
|
---|
Capitalization
1 |
191,588
|
Enterprise Value (EV)
1 |
166,406
|
P/E ratio
|
-20.3
x
|
Yield
|
-
|
Capitalization / Revenue
|
-
|
EV / Revenue
|
-
|
EV / EBITDA
|
-17.6
x
|
EV / FCF
|
-26,831,710
x
|
FCF Yield
|
-0%
|
Price to Book
|
6.76
x
|
Nbr of stocks (in thousands)
|
12,919
|
Reference price
2 |
14,830
|
Announcement Date
|
3/20/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
421.1
|
187.7
|
57
|
300
|
-
|
EBITDA
1 |
-2,632
|
-5,891
|
-8,056
|
-10,041
|
-9,432
|
EBIT
1 |
-2,749
|
-6,047
|
-8,406
|
-10,619
|
-10,117
|
Operating Margin
|
-652.76%
|
-3,221.87%
|
-14,747.26%
|
-3,539.83%
|
-
|
Earnings before Tax (EBT)
1 |
-4,951
|
-13,398
|
-31,471
|
-17,062
|
-8,858
|
Net income
1 |
-4,951
|
-13,398
|
-31,471
|
-17,062
|
-8,858
|
Net margin
|
-1,175.82%
|
-7,138.82%
|
-55,211.94%
|
-5,687.23%
|
-
|
EPS
2 |
-892.0
|
-2,370
|
-5,423
|
-1,921
|
-732.0
|
Free Cash Flow
|
-
|
2,769
|
14,875
|
-50,167
|
-6,202
|
FCF margin
|
-
|
1,475.21%
|
26,097.29%
|
-16,722.19%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/29/21
|
6/29/21
|
4/22/22
|
4/10/23
|
3/20/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
3,821
|
14,219
|
23,221
|
14,714
|
25,182
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
2,769
|
14,875
|
-50,167
|
-6,202
|
ROE (net income / shareholders' equity)
|
-
|
923%
|
378%
|
-1,826%
|
-38.5%
|
ROA (Net income/ Total Assets)
|
-
|
-32.6%
|
-23.8%
|
-28.7%
|
-26.1%
|
Assets
1 |
-
|
41,047
|
132,347
|
59,391
|
33,912
|
Book Value Per Share
2 |
-1,221
|
-103,623
|
-8,819
|
1,539
|
2,194
|
Cash Flow per Share
2 |
649.0
|
50,695
|
3,241
|
332.0
|
1,207
|
Capex
1 |
72.6
|
264
|
1,170
|
328
|
840
|
Capex / Sales
|
17.24%
|
140.87%
|
2,052.22%
|
109.43%
|
-
|
Announcement Date
|
6/29/21
|
6/29/21
|
4/22/22
|
4/10/23
|
3/20/24
|
|
1st Jan change
|
Capi.
|
---|
| -27.51% | 101M | | +15.20% | 121B | | +19.67% | 113B | | +18.95% | 26.02B | | -23.86% | 19.39B | | -19.03% | 15.91B | | -20.90% | 15.09B | | -46.14% | 15.06B | | +63.85% | 14.93B | | +4.49% | 13.85B |
Bio Therapeutic Drugs
|